Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-010142

Chairman and CEO bought 12,000 shares at $1.45 ($17,400)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2022-02-14 Purchase +6,000 $1.45 $8,700 11,200,406 D
Niihara Yutaka Chairman and CEO 2022-02-15 Purchase +6,000 $1.45 $8,700 11,206,406 D
Open-market purchases · 12,000 sh · avg $1.45 · $17,400
Loading xslF345X03/doc4.xml…